338 related articles for article (PubMed ID: 36980725)
1. Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis.
Lee JC; Logan AC
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980725
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of hemophagocytic lymphohistiocytosis: a retrospective study comparing adult macrophage activation syndrome to malignancy-associated hemophagocytic lymphohistiocytosis.
Good SD; Wade SD; Kyttaris VC
Rheumatol Int; 2022 Jul; 42(7):1247-1255. PubMed ID: 35015099
[TBL] [Abstract][Full Text] [Related]
3. Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis.
Song Y; Wang J; Wang Y; Wu L; Wang Z
Cancer Biol Ther; 2021 Dec; 22(10-12):598-606. PubMed ID: 34724875
[TBL] [Abstract][Full Text] [Related]
4. Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series.
Pasvolsky O; Zoref-Lorenz A; Abadi U; Geiger KR; Hayman L; Vaxman I; Raanani P; Leader A
Int J Hematol; 2019 May; 109(5):553-562. PubMed ID: 30850926
[TBL] [Abstract][Full Text] [Related]
5. Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis.
Song Y; Yin Q; Wang J; Wang Z
Cell Transplant; 2021; 30():9636897211057077. PubMed ID: 34743574
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis.
Chen W; Zhang S; Zhang W; Yang X; Xu J; Qiu H; Zhang X; Li J
Int J Lab Hematol; 2015 Aug; 37(4):544-50. PubMed ID: 25764155
[TBL] [Abstract][Full Text] [Related]
7. Hereditary and acquired hemophagocytic lymphohistiocytosis.
Zhang L; Zhou J; Sokol L
Cancer Control; 2014 Oct; 21(4):301-12. PubMed ID: 25310211
[TBL] [Abstract][Full Text] [Related]
8. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.
Zhou L; Liu Y; Wen Z; Yang S; Li M; Zhu Q; Qiu S; Gao Y; Wang H; Yuan Y; Zhang H; Chen C; Zeng W; Guan Z; Pan X
J Cancer Res Clin Oncol; 2020 Nov; 146(11):3063-3074. PubMed ID: 32617699
[TBL] [Abstract][Full Text] [Related]
9. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
[No Abstract] [Full Text] [Related]
10. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.
Tamamyan GN; Kantarjian HM; Ning J; Jain P; Sasaki K; McClain KL; Allen CE; Pierce SA; Cortes JE; Ravandi F; Konopleva MY; Garcia-Manero G; Benton CB; Chihara D; Rytting ME; Wang S; Abdelall W; Konoplev SN; Daver NG
Cancer; 2016 Sep; 122(18):2857-66. PubMed ID: 27244347
[TBL] [Abstract][Full Text] [Related]
11. A Case of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to T Cell Lymphoma and Cytomegalovirus (CMV) Infection and Complicated by Tumor Lysis Syndrome (TLS).
Kilani Y; Laxamana T; Mahfooz K; Yusuf MH; Perez-Gutierrez V; Shabarek N
Am J Case Rep; 2022 Apr; 23():e935915. PubMed ID: 35361746
[TBL] [Abstract][Full Text] [Related]
12. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
Yan WL; Yang SL; Zhao FY; Xu XJ
J Oncol Pharm Pract; 2022 Jan; 28(1):222-227. PubMed ID: 34074166
[TBL] [Abstract][Full Text] [Related]
13. Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS.
Liu X; Zhu X; Zhou X; Xie Y; Xiang D; Wan Z; Huang Y; Zhu B
Front Immunol; 2022; 13():1012643. PubMed ID: 36263041
[TBL] [Abstract][Full Text] [Related]
14. Etoposide combined with ruxolitinib for refractory hemophagocytic lymphohistiocytosis during pregnancy: a case report and literature review.
Wang S; Wu J; Jing X; Zhang Y; Tang H; Wu J
Hematology; 2019 Dec; 24(1):751-756. PubMed ID: 33138732
[TBL] [Abstract][Full Text] [Related]
15. Severe Lymphoma-Associated Hemophagocytic Syndrome in a Young Woman.
Ali K; Medina J; Benedetto PW
Cureus; 2024 Feb; 16(2):e53649. PubMed ID: 38449949
[TBL] [Abstract][Full Text] [Related]
16. Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.
Keenan C; Nichols KE; Albeituni S
Front Immunol; 2021; 12():614704. PubMed ID: 33664745
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions.
Wang H; Xiong L; Tang W; Zhou Y; Li F
Oncotarget; 2017 Aug; 8(35):59977-59985. PubMed ID: 28938698
[TBL] [Abstract][Full Text] [Related]
18. A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.
Summerlin J; Wells DA; Anderson MK; Halford Z
Ann Pharmacother; 2023 Jul; 57(7):867-879. PubMed ID: 36349896
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Review of Secondary Hemophagocytic Lymphohistiocytosis (HLH) and Dengue-associated HLH from a Teaching Hospital in Singapore.
Tso ACY; Acharyya S; Fong SZ; Lee LK; Sreekanth SV; Fan BE; Chan SWS; Ong KH
Clin Hematol Int; 2024; 6(1):116-127. PubMed ID: 38817699
[TBL] [Abstract][Full Text] [Related]
20. Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study.
Scholz L; Posch F; Schulz E; Gornicec M; Wölfler A; Reisinger AC; Reinisch A; Eller P; Eisner F; Kreuzer P; Stradner M; Rosenkranz AR; Krammer F; Schilcher G; Krause R; Hatzl S
Crit Care Explor; 2024 Feb; 6(2):e1046. PubMed ID: 38511127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
